Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Kogner

Showing results (101-110 of 168) with videos related to

Pageof 17
Sort By:
Plos One|January 18, 2018
Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastomaIsabell Hultman, Linnea Haeggblom, Ingvild Rognmo, et al.
Oncogene|December 14, 2018
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastomaØyvind H Hald, Lotte Olsen, Gabriel Gallo-Oller, et al.
Genes, Chromosomes & Cancer|September 25, 2014
Intragenic anaplastic lymphoma kinase (ALK) rearrangements: translocations as a novel mechanism of ALK activation in neuroblastoma tumorsSusanne Fransson, Magnus Hansson, Kristina Ruuth, et al.
Cancer Research|November 10, 2010
Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapyTommy Martinsson, Therese Eriksson, Jonas Abrahamsson, et al.
Molecular Cancer Therapeutics|September 19, 2007
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivoMalin Wickström, John Inge Johnsen, Frida Ponthan, et al.
Cancers|December 10, 2021
<i>PPM1D</i> Is a Therapeutic Target in Childhood Neural TumorsJelena Milosevic, Diana Treis, Susanne Fransson, et al.
Genes, Chromosomes & Cancer|July 20, 2024
Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere MaintenanceAnna Djos, Johanna Svensson, Jennie Gaarder, et al.
International Journal of Cancer|March 31, 2006
The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivoLiv Tone Eliassen, Gerd Berge, Arild Leknessund, et al.
International Journal of Oncology|February 28, 2013
Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesisIngvild Pettersen, Ninib Baryawno, Frida Abel, et al.
Plos One|December 17, 2009
DNA from KI, WU and Merkel cell polyomaviruses is not detected in childhood central nervous system tumours or neuroblastomasGéraldine Giraud, Torbjörn Ramqvist, Diana V Pastrana, et al.
Pageof 17

Showing results (101-110 of 168) with videos related to

Sort By:
Pageof 17
Plos One|January 18, 2018
Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastomaIsabell Hultman, Linnea Haeggblom, Ingvild Rognmo, et al.
Oncogene|December 14, 2018
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastomaØyvind H Hald, Lotte Olsen, Gabriel Gallo-Oller, et al.
Genes, Chromosomes & Cancer|September 25, 2014
Intragenic anaplastic lymphoma kinase (ALK) rearrangements: translocations as a novel mechanism of ALK activation in neuroblastoma tumorsSusanne Fransson, Magnus Hansson, Kristina Ruuth, et al.
Cancer Research|November 10, 2010
Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapyTommy Martinsson, Therese Eriksson, Jonas Abrahamsson, et al.
Molecular Cancer Therapeutics|September 19, 2007
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivoMalin Wickström, John Inge Johnsen, Frida Ponthan, et al.
Cancers|December 10, 2021
<i>PPM1D</i> Is a Therapeutic Target in Childhood Neural TumorsJelena Milosevic, Diana Treis, Susanne Fransson, et al.
Genes, Chromosomes & Cancer|July 20, 2024
Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere MaintenanceAnna Djos, Johanna Svensson, Jennie Gaarder, et al.
International Journal of Cancer|March 31, 2006
The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivoLiv Tone Eliassen, Gerd Berge, Arild Leknessund, et al.
International Journal of Oncology|February 28, 2013
Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesisIngvild Pettersen, Ninib Baryawno, Frida Abel, et al.
Plos One|December 17, 2009
DNA from KI, WU and Merkel cell polyomaviruses is not detected in childhood central nervous system tumours or neuroblastomasGéraldine Giraud, Torbjörn Ramqvist, Diana V Pastrana, et al.
Pageof 17